|
Status |
Public on Oct 05, 2021 |
Title |
C-FOS-driven basal to squamous cell transition |
Organism |
Mus musculus |
Experiment type |
Genome binding/occupancy profiling by high throughput sequencing Expression profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
34610301 |
|
Submission date |
Mar 05, 2021 |
Last update date |
Oct 19, 2021 |
Contact name |
Anthony Oro |
Organization name |
Stanford University
|
Department |
Dermatology
|
Street address |
269 Campus Drvie
|
City |
Stanford |
State/province |
CA |
ZIP/Postal code |
94305 |
Country |
USA |
|
|
Platforms (4)
|
GPL13112 |
Illumina HiSeq 2000 (Mus musculus) |
GPL19057 |
Illumina NextSeq 500 (Mus musculus) |
GPL21103 |
Illumina HiSeq 4000 (Mus musculus) |
GPL24247 |
Illumina NovaSeq 6000 (Mus musculus) |
|
Samples (47)
|
|
This SuperSeries is composed of the following SubSeries:
|
GSE161009 |
Chromatin accessibility changes in experimentally-induced basal to squamous cell carcinoma transition (BST) |
GSE166593 |
Transcriptional changes in experimentally-induced basal to squamous cell carcinoma transition (BST) [ASZ_RasV12_TGFbR1_RNAseq] |
GSE166595 |
Transcriptional changes in experimentally-induced basal to squamous cell carcinoma transition (BST) [ASZ_cFOS_RNAseq] |
GSE166596 |
Transcriptional changes in experimentally-induced basal to squamous cell carcinoma transition (BST) upon treatment with small molecule inhibitors [ASZ_RNAseq_inhibitor] |
GSE168374 |
DNA binding profile of c-FOS in experimentally-induced basal to squamous cell carcinoma transition (BST) |
GSE178914 |
Chromatin accessibility changes in experimentally-induced basal to squamous cell carcinoma transition (BST) upon EGFR/MAPK inhibitor treatments [ASZ_ATACseq_inhibitor] |
|
Relations |
BioProject |
PRJNA707051 |